Métodos: Estudio observacional, prospectivo, que incluye 270 pacientes sometidos a
cateterismo transradial electivo desde enero de 2013 hasta noviembre de 2017, divididos …

Generic entry of newer anticoagulants is expected to decrease the costs of atrial fibrillation
management. However, when making switches between brand and generic medications …

Introduction and objectives: Today it has become increasingly common to perform
procedures without withdrawing oral anticoagulation. However, the need to withdraw oral …

SOUHRN Úvod: Fibrilace síní (FS) je poruchou srdečního rytmu s prevalencí 3, 37%
populace, která roste s věkem. 1 Pacienti s FS mají vysoké riziko cévní mozkové příhody …

Par conséquent, il n'est pas étonnant que les gouvernements aient réagi à l'introduction des
ACOD en publiant des restrictions à leur prescription; le libellé, dans les formulaires …

This study has several limitations: 1) The use of NOACs including rivaroxaban was
extremely low, and 2) the events were analyzed using 2012–2014 data from the Health …

Atrial fibrillation (AF) is the most common chronic arrhythmia, with increasing healthcare and
economic burden and a prevalence which increases with progressive ageing. This study …

Background: Despite treatment-guideline recommendations and availability medications to
reduce stroke risk, widespread underutilization of oral anticoagulants (OACs) has been …

Background: Despite treatment-guideline recommendations and availability medications to
reduce stroke risk, widespread underutilization of oral anticoagulants (OACs) has been …

Novel oral anticoagulants (NOACs) have uncomplicated dosing with no need for INR
monitoring and fewer possible drug and food interactions compared to warfarin, which may …